Baidu
map

JAMA Pediatr:十年期间美国婴儿发生围产期艾滋病毒感染现状

2017-03-23 MedSci MedSci原创

目前,可以通过抗逆转录病毒治疗和预防来减少人类免疫缺陷病毒(HIV)在围产期的传播。尚需对围产期艾滋病毒传播和漏失预防机会的数据进行统计,以监测消除母婴传播艾滋病毒的进展情况。近期,一项发表在杂志JAMA Pediatr上的研究旨在评估美国出生的婴儿中发生围产期艾滋病毒病例的数量。此项研究的数据来自国家艾滋病监测系统,统计2002年至2013年(截至2015年12月31日期间),美国(包括哥伦比亚

目前,可以通过抗逆转录病毒治疗和预防来减少人类免疫缺陷病毒(HIV)在围产期的传播。尚需对围产期艾滋病毒传播和漏失预防机会的数据进行统计,以监测消除母婴传播艾滋病毒的进展情况。


近期,一项发表在杂志JAMA Pediatr上的研究旨在评估美国出生的婴儿中发生围产期艾滋病毒病例的数量。

此项研究的数据来自国家艾滋病监测系统,统计2002年至2013年(截至2015年12月31日期间),美国(包括哥伦比亚特区)出生的艾滋病毒婴幼儿和其母亲的数据。根据从出生到诊断和报告时间合并的模式,对每个报告病例进行加权,对诊断和报告的延迟进行了调整。分析于2016年4月1日至8月15日进行。

此项研究的暴露因素是孕产妇感染艾滋病毒和使用抗逆转录病毒药物。

此项研究结果显示:在美国出生的围产期感染婴儿估计数从2002年的216(95%CI,206-230)下降到2013年的69(95%CI,60-83)。在2002-2013年出生的围产期艾滋病毒感染儿童中,836名患儿(63.0%)的母亲被确定为黑人或非裔美国人;243名(18.3%)为西班牙裔或拉丁裔。
 
2002 - 2005年期间,共有236例(37.5%)的母亲在怀孕前诊断出艾滋病毒感染,而2010 - 2013年为120例(51.5%);在2002 - 2005年期间,接受全部3个推荐的抗逆转录病毒预防或治疗药物(产前,产后和出生后)的母婴对的比例为22.4%,而2010-2013年为31.8%,其中约179例(28.4%)(2002- 2005年)和94例(40.3%)(2010-2013年)在怀孕期间接受抗逆转录病毒预防或治疗。

整个研究期间,美国五大南部州(佛罗里达州,德克萨斯州,格鲁吉亚,路易斯安那州和马里兰州)占美国感染艾滋病毒婴儿的687人(38.0%)。根据国家生活活动情况,2013年美国出生的婴儿中,围产期HIV感染发生率为每10万活产婴儿有1.75人。

此项研究表明:尽管美国的围产期艾滋病毒感染减少,但是近年来,受感染婴儿及其母亲的预防机会也经常错失。疾病控制和预防中心拟议的消除母婴传播艾滋病毒的目标是每10万活产婴儿中1人,但截至2013年,围产期艾滋病毒感染的发生率仍然是这一目标的1.75倍。

原始出处:
Taylor AW, Nesheim SR, et al. Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013. JAMA Pediatr. 2017 Mar 20. doi: 10.1001/jamapediatrics.2016.5053.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1637646, encodeId=eb53163e64602, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 02 21:06:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726324, encodeId=776b1e2632412, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Jun 30 12:06:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948842, encodeId=a461194884289, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Fri Oct 13 07:06:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183649, encodeId=2334183649b4, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Thu Mar 30 02:48:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182399, encodeId=ea2118239938, content=非常好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Mar 24 12:22:17 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182244, encodeId=6b5518224444, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Thu Mar 23 20:59:57 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1637646, encodeId=eb53163e64602, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 02 21:06:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726324, encodeId=776b1e2632412, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Jun 30 12:06:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948842, encodeId=a461194884289, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Fri Oct 13 07:06:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183649, encodeId=2334183649b4, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Thu Mar 30 02:48:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182399, encodeId=ea2118239938, content=非常好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Mar 24 12:22:17 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182244, encodeId=6b5518224444, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Thu Mar 23 20:59:57 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-06-30 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=1637646, encodeId=eb53163e64602, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 02 21:06:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726324, encodeId=776b1e2632412, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Jun 30 12:06:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948842, encodeId=a461194884289, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Fri Oct 13 07:06:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183649, encodeId=2334183649b4, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Thu Mar 30 02:48:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182399, encodeId=ea2118239938, content=非常好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Mar 24 12:22:17 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182244, encodeId=6b5518224444, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Thu Mar 23 20:59:57 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1637646, encodeId=eb53163e64602, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 02 21:06:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726324, encodeId=776b1e2632412, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Jun 30 12:06:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948842, encodeId=a461194884289, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Fri Oct 13 07:06:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183649, encodeId=2334183649b4, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Thu Mar 30 02:48:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182399, encodeId=ea2118239938, content=非常好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Mar 24 12:22:17 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182244, encodeId=6b5518224444, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Thu Mar 23 20:59:57 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-03-30 飘飘爱

    很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1637646, encodeId=eb53163e64602, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 02 21:06:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726324, encodeId=776b1e2632412, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Jun 30 12:06:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948842, encodeId=a461194884289, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Fri Oct 13 07:06:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183649, encodeId=2334183649b4, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Thu Mar 30 02:48:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182399, encodeId=ea2118239938, content=非常好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Mar 24 12:22:17 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182244, encodeId=6b5518224444, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Thu Mar 23 20:59:57 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-03-24 天涯183

    非常好的研究

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1637646, encodeId=eb53163e64602, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue May 02 21:06:00 CST 2017, time=2017-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1726324, encodeId=776b1e2632412, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Fri Jun 30 12:06:00 CST 2017, time=2017-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948842, encodeId=a461194884289, content=<a href='/topic/show?id=8b7b86814c6' target=_blank style='color:#2F92EE;'>#艾滋病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86814, encryptionId=8b7b86814c6, topicName=艾滋病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9dd613, createdName=xxxx1049, createdTime=Fri Oct 13 07:06:00 CST 2017, time=2017-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183649, encodeId=2334183649b4, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2emBzjO0FtqTJ05AqrEEdRmp6tmlsLXqpzfxWdtgbbgPGWRHagoK9fLTd3IayRPgkJVIVBWtdlmnkBhOIR4cFM/0, createdBy=e8d51649330, createdName=飘飘爱, createdTime=Thu Mar 30 02:48:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182399, encodeId=ea2118239938, content=非常好的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Fri Mar 24 12:22:17 CST 2017, time=2017-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=182244, encodeId=6b5518224444, content=签到学习了很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Thu Mar 23 20:59:57 CST 2017, time=2017-03-23, status=1, ipAttribution=)]
    2017-03-23 Chongyang Zhang

    签到学习了很多

    0

相关资讯

卫计委:《预防艾滋病、梅毒和乙肝母婴传播工作实施方案(2015年版)》发布

6月16日,卫计委在其官网上发布了关于全面开展预防艾滋病、梅毒和乙肝母婴传播工作的通知。通知强调,为进一步控制艾滋病、梅毒和乙肝母婴传播,力争率先在儿童中实现“零艾滋”、消除儿童新发感染,卫计委决定自2015年起在全国全面开展预防艾滋病、梅毒和乙肝母婴传播工作。卫计委要求各地要按照《预防艾滋病、梅毒和乙肝母婴传播工作实施方案(2015年版)》(以下简称方案),结合本地实际,进一步完善本地具体实施方

Lancet:两种处方预防HIV母婴传播效果相当

目前,母乳喂养仍然是预防HIV-1母婴传播的重要障碍。与预防成年人性行为传播HIV相似,预防母乳喂养传播HIV主要有两种方法:1.通过对已经感染的患者的治疗,降低传染力(母体抗病毒治疗,ART);2.对尚未被感染的婴儿进行抗病毒预防(PreP)。临床试验表明,婴儿PreP和母体ART都是有效的。但是,目前仍然没有关于婴儿暴露超过六个月的的处方。而目前推荐的哺乳时间为12个月。 为此,研究

Obstet Gynecol:预防艾滋病母婴传播有哪些机会?

尽管患者得到了高水平的护理及随访,但一小部分的HIV感染的孕妇会将病毒传播给胎儿。这个病例系列为围产期艾滋病的传播的影响因素提供了新的认识,并可以为制定预防艾滋病毒母婴传播的新战略提供依据。

前沿 | 中国专家成功阻断乙肝母婴传播

如何让宝宝远离乙肝(HBV)?近日,首都医科大学附属的北京佑安医院妇幼中心名誉主任潘启安教授领衔的中国科研团队发现,高乙肝病毒载量的孕妇在服用抗病毒药物“替诺福韦”(TDF, tenofovir disoproxil fumarate)后,能大幅降低乙肝母婴传播风险。经治后,婴儿从母亲处感染乙肝的风险能降至5%,甚至0%。 乙肝母婴传播是指,患乙型肝炎或无症状的乙肝表面抗原(HBsAg)孕妇携

Obstetrics & Gynecology:母婴艾滋病毒传播率有上升的趋势

根据 4 月份“妇产科”发表的研究,少数受艾滋病毒感染的妇女继续将病毒传播给他们的新生儿,尽管获得高质量的护理。来自迈阿密米勒医学院的 Gwendolyn B.Scott,M.D. 和同事审查了从 2002 年至 2009 年出生的艾滋病毒感染儿童和艾滋病毒感染妇女有关的数据。作者描述了艾滋病毒感染的婴儿及其母亲的特点,以及母亲的临床管理。研究人员在 1,857 名新生儿中发现了 12 例母婴传播

2015年关于HIV/AIDS的10大事实

尽管目前对HIV/AIDS的认识等有重大进展,但是HIV/AIDS依旧是全球范围内重大公共卫生挑战,尤其是低中收入国家;撒哈拉以南非洲女性风险尤其高。自1984年起,每年的12月1日作为世界艾滋病日,这一天将举办各种宣传和普及预防艾滋病的知识有关活动,意在团结大众抵抗HIV,支持HIV感染人群,纪念已故人群。9月联合国成员达成一致协议:将于2030年终结AIDS的流行。虽然目标宏伟,但根据WHO、

Baidu
map
Baidu
map
Baidu
map